In Vitro and in vivo activity of ARRY-380: A potent, small molecule inhibitor of ErbB2.

被引:0
|
作者
Pheneger, Tracy [1 ]
Bouhana, Karyn [1 ]
Anderson, Deborah [1 ]
Garrus, Jennifer [1 ]
Ahrendt, Kateri [1 ]
Allen, Shelley [1 ]
Von Carlowitz, Ira [1 ]
Greschuk, Julie [1 ]
Gross, Stefan [1 ]
Hoffman, Keith [1 ]
Lemieux, Christine [1 ]
Lyssikatos, Joe [1 ]
Callejo, Michele [1 ]
Tarlton, Gene [1 ]
Wallace, Eli [1 ]
Winski, Shannon [1 ]
Woessner, Rich [1 ]
Zhao, Qian [1 ]
Marmsater, Fred [1 ]
Lee, Patrice [1 ]
机构
[1] Array BioPharma, Boulder, CO USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1795
引用
收藏
页数:2
相关论文
共 50 条
  • [21] 2-amino-4-methylpyridine as a potent inhibitor of inducible NO synthase activity in vitro and in vivo
    Faraci, WS
    Nagel, AA
    Verdries, KA
    Vincent, LA
    Xu, H
    Nichols, LE
    Labasi, JM
    Salter, ED
    Pettipher, ER
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 (06) : 1101 - 1108
  • [22] A POTENT SMALL MOLECULE PIM KINASE INHIBITOR WITH IN VIVO ORAL AVAILABILITY AND ACTIVITY IN CELL LINES FROM HEMATOLOGICAL MALIGNANCIES
    Berk, G.
    Gourley, E.
    Liu, X. H.
    Lamb, J.
    Severson, F.
    Bearss, J.
    Jones, C.
    Vankayalapati, H.
    Warner, S.
    Bearss, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 113 - 113
  • [23] Characterization of a Novel, Potent and Selective Small Molecule Spleen Tyrosine Kinase (SYK) Inhibitor in In Vitro and In Vivo Models of Asthma.
    Crackower, M. A.
    Moy, L. Y.
    Jia, Y.
    Yu, H.
    Vincent, S.
    Miller, J. R.
    Lieber, G.
    Fernandez, X.
    Caniga, M.
    Gil, M.
    Wilhelm, A.
    Houshyar, H.
    Northrup, A.
    Chapman, R.
    Abraham, W. M.
    Kelly, N.
    Hickey, E.
    Miller, T.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB49 - AB49
  • [24] IN VITRO AND IN VIVO ANTIVIRAL ACTIVITIES OF AB-423 A POTENT SMALL MOLECULE INHIBITOR OF HEPATITIS B VIRUS CAPSID ASSEMBLY
    Mani, N.
    Cole, A.
    Phelps, J.
    Ardzinski, A.
    Cobarrubias, K.
    Cuconati, A.
    Dorsey, B.
    Evangelista, E.
    Harasym, T.
    Kadhim, S.
    Lee, A.
    Liang, H.
    Li, A.
    McClintock, K.
    Majeski, S.
    Reid, S.
    Rijnbrand, R.
    Tang, S.
    Wang, X.
    Sofia, M.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S392 - S393
  • [25] In vivo and pharmacodynamic profiling of the KSP inhibitor ARRY-520 supports potent activity in hematological cancers and drug resistant tumors
    Woessner, Rich
    Cox, April
    Koch, Kevin
    Lee, Patrice
    Rana, Sumeet
    Tunquist, Brian
    Walker, Duncan
    Winkler, Jim
    CANCER RESEARCH, 2009, 69
  • [26] In vitro and in vivo activity of a new small-molecule inhibitor of HDAC6 in mantle cell lymphoma
    Perez-Salvia, Montserrat
    Aldaba, Eneko
    Vara, Yosu
    Fabre, Myriam
    Ferrer, Cristina
    Masdeu, Carme
    Zubia, Aizpea
    San Sebastian, Eider
    Otaegui, Dorleta
    Llinas-Arias, Pere
    Rossello-Tortella, Margalida
    Berdasco, Maria
    Moutinho, Catia
    Setien, Fernando
    Villanueva, Alberto
    Gonzalez-Barca, Eva
    Muncunill, Josep
    Navarro, Jose-Tomas
    Piris, Miguel A.
    Cossio, Fernando P.
    Esteller, Manel
    HAEMATOLOGICA, 2018, 103 (11) : E537 - E540
  • [27] S-222611, a potent, orally active small molecule inhibitor of EGFR and HER2: in vitro kinase inhibition and antitumor activity
    Hirata, Michinari
    Tanaka, Hidekazu
    Dohi, Keiji
    Iguchi, Motofumi
    Wada, Tohru
    Matsuo, Kenji
    Kume, Masaharu
    Omori, Naoki
    Tada, Yukio
    Orita, Satoshi
    Abe, Kenji
    Arimura, Akinori
    Matsuo, Yoshiyuki
    Kato, Akira
    CANCER RESEARCH, 2009, 69
  • [28] ACC inhibitor demonstrates potent anti-fibrotic activity in vitro and in vivo
    Bates, J.
    Ghoshal, S.
    Wei, L.
    Hollenback, D.
    Liu, K.
    Kusam, S.
    Sulfab, M.
    Liu, H.
    Brockett, R.
    Newstrom, D.
    Mikaelian, I.
    Wang, T.
    Harriman, G.
    Westlin, W. F.
    Rocnik, J.
    Harwood, H. J.
    Kapeller, R.
    Ray, A.
    Breckenridge, D.
    Fuchs, B. C.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S399 - S400
  • [29] Preclinical characterization of ARRY-575: a potent, selective, and orally bio-available small molecule inhibitor of Chk1
    Humphries, M. J.
    von Carlowitz, I.
    Le Huerou, Y. L.
    Randolph, N.
    Gunawardana, I.
    Mohr, P. J.
    Wang, B.
    Lyon, M. A.
    Chicarelli, M.
    Sullivan, F.
    Blake, J. F.
    Winski, S. L.
    Wallace, E.
    ANNALS OF ONCOLOGY, 2011, 22 : 23 - 23
  • [30] A Lipopeptide HIV-1/2 Fusion Inhibitor with Highly Potent In Vitro, Ex Vivo, and In Vivo Antiviral Activity
    Chong, Huihui
    Xue, Jing
    Xiong, Shengwen
    Cong, Zhe
    Ding, Xiaohui
    Zhu, Yuanmei
    Liu, Zixuan
    Chen, Ting
    Feng, Yifan
    He, Lei
    Guo, Yan
    Wei, Qiang
    Zhou, Yusen
    Qin, Chuan
    He, Yuxian
    JOURNAL OF VIROLOGY, 2017, 91 (11)